ZTS
Stock Details
ZTS is Zoetis Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 152.35$. Average daily volumn in 3 months 2.49M. Market cap 76.99B
Stock symbol : ZTS. Exchange : NYSE. Currency : USD Lastest price : 165.18$. Total volume : 1.83M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Zoetis Inc. (ZTS)
Last Price
165.18$Change
-3.06Volume
1.83M
| Previous Close | 168.24 |
| Open | 166.98 |
| Day Range | 164.50-167.69 |
| Bid | 0.00 x 1k |
| Ask | 0.00 x 900 |
| Volume | 1.83M |
| Average Volume | 2.49M |
| Market Cap | 76.99B |
| Beta | 0.72 |
| 52 Week Range | 124.15-205.31 |
| Trailing P/E | 37.71 |
| Foward P/E | 30.93 |
| Dividend (Yield %) | 0.91% |
| Ex-Dividend Date | 2023-01-19 |
Financial Details
Organization
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or ... induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Market Cap:
76.99BRevenue:
7.78BTotal Assets:
13.9BTotal Cash:
3.48B
News about "Zoetis Inc."
Zoetis Inc.
Source from : Barron's - 9 days ago
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...See details»
Zoetis Inc. (NYSE: ZTS): Is Its Value Too High Compared To Others?
Source from : stocksregister - 10 days ago
Zoetis Inc. (NYSE:ZTS) shares, rose in value on Thursday, January 19, with the stock price up by 0.17% to the previous day’s close as strong demand from buyers drove the stock to $160.24. Actively ...See details»
Zoetis Inc.: Maintaining BUY and $190 target
Source from : Yahoo Finance - 17 days ago
Zoetis Inc., a 2013 spinoff from Pfizer, focuses on the development, manufacture and commercialization of animal health vaccines and medicines, including parasiticides, anti-infectives ...See details»
Zoetis Inc.'s (NYSE:ZTS) Share Price Not Quite Adding Up
Source from : Yahoo - 1 month ago
With a price-to-earnings (or "P/E") ratio of 32.7x Zoetis Inc. (NYSE:ZTS) may be sending very bearish signals at the moment, given that almost half of all companies in the United States have P/E ...See details»
3 Reasons to Buy Zoetis, and 1 Reason to Sell
Source from : The Motley Fool - 11 days ago
Zoetis is penetrating its markets and bolstering its margins over time. It's also the leader in its industry, which won't change anytime soon. Factors outside the company's control are still ...See details»
Zoetis Inc PAC Contributions to Federal Candidates
Source from : OpenSecrets.org - 1 year ago
Based on data released by the Federal Election Commission on December 12, 2022. NOTE: Negative numbers may result from PACs making a contribution in one cycle and receiving a refund in a subsequent ...See details»
PAC Profile: Zoetis Inc
Source from : OpenSecrets.org - 1 year ago
*Based on data released by the Federal Election Commission on January 13, 2023 except for independent expenditure and communication cost, contributions to federal candidates, and contributions from ...See details»
Zoetis Inc - Ordinary Shares - Class A
Source from : U.S. News & World Report - 1 month ago
Broad market weakness has dropped the share prices of many value stocks.See details»
Zoetis (ZTS)’s Revenue Growth May Decelerate Due to Multiple Headwinds
Source from : Insider Monkey - 1 month ago
Renaissance Investment highlighted stocks like Zoetis Inc. (NYSE:ZTS) in its Q3 2022 investor letter. Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health company.See details»
Highlights from the Ratings and Financial Report for Zoetis Inc. (ZTS)
Source from : newsheater - 1 year ago
Zoetis Inc. (NYSE:ZTS) went up by 0.25% from its latest closing price compared to the recent 1-year high of $206.25. The company’s stock price has collected 3.63% of gains in the last five trading ...See details»
Why Zoetis Stock Lost 40% in 2022
Source from : MSN - 17 days ago
Shares of Zoetis (NYSE: ZTS) were losing ground in 2022 as the pet pharmacist saw headwinds related to a slowdown in the pet sector. A compression in valuations in growth stocks due to rising ...See details»
Zoetis Is An Awesome Dividend Growth Stock
Source from : Seeking Alpha - 11 days ago
In this article, I'm initiating coverage of Zoetis, the world's leading animal healthcare company. While the stock has a low yield of less than 1%, the company has terrific financials, fast growth ...See details»
Zoetis Stock (NYSE:ZTS): Analysts are Unanimously Bullish Despite Last Year’s Tumble
Source from : Business Insider - 11 days ago
In many cases, when a publicly-traded stock like drug manufacturer Zoetis (NYSE:ZTS) tumbles double digits for the year, analysts typically run away. However, that’s not the case at all with ZTS ...See details»
It's A Great Time To Buy Zoetis Shares
Source from : Seeking Alpha - 19 days ago
Zoetis has a very strong competitive moat resulting from its patents, scale, and respected brands. It has been delivering above-market growth for many years, and its profit margins have been on an ...See details»